The potential role of MGMT rs12917 polymorphism in cancer risk: an updated pooling analysis with 21010 cases and 34018 controls
- PMID: 30232235
- PMCID: PMC6435461
- DOI: 10.1042/BSR20180942
The potential role of MGMT rs12917 polymorphism in cancer risk: an updated pooling analysis with 21010 cases and 34018 controls
Erratum in
-
Correction: The potential role of MGMT rs12917 polymorphism in cancer risk: an updated pooling analysis with 21010 cases and 34018 controls.Biosci Rep. 2019 Jan 11;39(1):BSR-20180942_COR. doi: 10.1042/BSR-20180942_COR. Print 2019 Jan 31. Biosci Rep. 2019. PMID: 30635450 Free PMC article. No abstract available.
Abstract
In the present study, we aimed at determining the potential role of rs12917 polymorphism of the O-6-methylguanine-DNA methyltransferase (MGMT) gene in the occurrence of cancer. Based on the available data from the online database, we performed an updated meta-analysis. We retrieved 537 articles from our database research and finally selected a total of 54 case-control studies (21010 cases and 34018 controls) for a series of pooling analyses. We observed an enhanced risk in cancer cases compared with controls, using the genetic models T/T compared with C/C (P-value of association test <0.001; odds ratio (OR) = 1.29) and T/T compared with C/C+C/T (P<0.001; OR = 1.32). We detected similar positive results in the subgroups 'Caucasian', and 'glioma' (all P<0.05; OR > 1). However, we detected negative results in our analyses of most of the other subgroups (P>0.05). Begg's and Egger's tests indicated that the results were free of potential publication bias, and sensitivity analysis suggested the stability of the pooling results. In summary, the T/T genotype of MGMT rs12917 is likely to be linked to an enhanced susceptibility to cancer overall, especially glioma, in the Caucasian population.
Keywords: Cancer; MGMT; meta-analysis; polymorphism.
© 2018 The Author(s).
Conflict of interest statement
The authors declare that there are no competing interests associated with the manuscript.
Figures





Similar articles
-
Association of the Promoter Methylation and the rs12917 Polymorphism of MGMT with Formation of DNA Bulky Adducts and the Risk of Lung Cancer in Mexican Mestizo Population.DNA Cell Biol. 2019 Apr;38(4):307-313. doi: 10.1089/dna.2018.4526. Epub 2019 Feb 20. DNA Cell Biol. 2019. PMID: 30785779
-
The Role of O6-methylguanine-DNA Methyltransferase Polymorphisms in Prostate Cancer Susceptibility: a Meta-Analysis.Pathol Oncol Res. 2020 Apr;26(2):1201-1209. doi: 10.1007/s12253-019-00672-7. Epub 2019 Jun 13. Pathol Oncol Res. 2020. PMID: 31190217
-
Impact of rs12917 MGMT Polymorphism on [18F]FDG-PET Response in Pediatric Hodgkin Lymphoma (PHL).Mol Imaging Biol. 2019 Dec;21(6):1182-1191. doi: 10.1007/s11307-019-01350-5. Mol Imaging Biol. 2019. PMID: 30945122
-
Two DNA repair gene polymorphisms on the risk of gastrointestinal cancers: a meta-analysis.Tumour Biol. 2014 Mar;35(3):1715-25. doi: 10.1007/s13277-013-1320-z. Epub 2013 Nov 8. Tumour Biol. 2014. PMID: 24203816 Review.
-
MGMT gene variants, temozolomide myelotoxicity and glioma risk. A concise literature survey including an illustrative case.J Chemother. 2017 Aug;29(4):238-244. doi: 10.1080/1120009X.2017.1312752. Epub 2017 Apr 23. J Chemother. 2017. PMID: 28436299 Review.
Cited by
-
Anlotinib reversed resistance to PD-1 inhibitors in recurrent and metastatic head and neck cancers: a real-world retrospective study.Cancer Immunol Immunother. 2024 Aug 6;73(10):199. doi: 10.1007/s00262-024-03784-5. Cancer Immunol Immunother. 2024. PMID: 39105897 Free PMC article.
-
Comprehensive assessment of the association between XPC rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls.Biosci Rep. 2019 Dec 20;39(12):BSR20192452. doi: 10.1042/BSR20192452. Biosci Rep. 2019. PMID: 31710080 Free PMC article.
-
Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study.J Neurooncol. 2022 Feb;156(3):625-634. doi: 10.1007/s11060-022-03944-6. Epub 2022 Jan 17. J Neurooncol. 2022. PMID: 35037156
-
Landscape of Germline Genetic Variants in AGT, MGMT, and TP53 in Mexican Adult Patients with Astrocytoma.Cell Mol Neurobiol. 2021 Aug;41(6):1285-1297. doi: 10.1007/s10571-020-00901-7. Epub 2020 Jun 13. Cell Mol Neurobiol. 2021. PMID: 32535722 Free PMC article.
References
-
- Christmann M., Verbeek B., Roos W.P. and Kaina B. (2011) O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry. Biochim. Biophys. Acta 1816, 179–190 - PubMed
-
- Nikolova T., Roos W.P., Kramer O.H., Strik H.M. and Kaina B. (2017) Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling. Biochim. Biophys. Acta 1868, 29–39 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials